---
title: "Health Authority Communication Plan Template"
methodology: "universal"
complexity: "advanced"
owner: "mirichard"
updated: "2026-09-19"
primary_principles: ["stakeholder-engagement", "stewardship"]
secondary_principles: ["evidence-based-decisions"]
principle_rationale: "Coordinates authorized health-authority submissions, responses and commitments through assigned communication roles and retained records."
---

# Health Authority Communication Plan

## When to Use

- When a regulated product needs planned communications with relevant health authorities.
- When authorized regulatory staff must coordinate submissions, responses, and commitments.

## When NOT to Use

- As permission to contact an authority or make commitments without organizational authorization.
- Do not represent author self-checks as independent or authorized approval. See [Self-approval](../../../../../docs/principles/anti-patterns.md#self-approval).

## Pairs Well With

- [Regulatory Strategy Plan Template](../../../../../domains/delivery/industry-specializations/healthcare-pharmaceutical/regulatory/regulatory_strategy_plan_template.md).
- [Regulatory Inspection Readiness Plan Template](../../../../../domains/delivery/industry-specializations/healthcare-pharmaceutical/regulatory/regulatory_inspection_readiness_plan_template.md).

Selection context: Delivery domain; universal methodology; advanced complexity. Match the situations above to project phase, risk, team size, and industry using the [decision-engine context model](../../../../../meta/architecture-research/800-801-context-assessment-model.md).

Reference check: [Current source](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp).


## Applying this template

Treat filled examples, dates, numerical limits, sampling frequencies, and approval outcomes as illustrations. Before execution, replace them with the approved product/site requirements, scientific rationale, method references, responsible reviewer, and acceptance evidence. Record the applicable jurisdiction and current guidance edition; a completed worksheet alone does not demonstrate regulatory compliance.

| Requirement or limit | Applicable source / edition | Product-specific rationale | Approval / date | Execution evidence |
|---|---|---|---|---|
| [Requirement] | [Source] | [Rationale] | [Reviewer / date] | [Record] |


## Document Control
- **Document ID:** [Unique Identifier]
- **Version:** [Version Number]
- **Date of Creation:** [Date]
- **Last Updated:** [Date]
- **Document Owner:** [Name/Title]
- **Approved By:** [Name/Title]
- **Status:** [Draft/In Review/Final]

## Table of Contents
1. [Purpose and Scope](#purpose-and-scope)
2. [Communication Strategy](#communication-strategy)
3. [Roles and Responsibilities](#roles-and-responsibilities)
4. [Communication Procedures](#communication-procedures)
5. [Timeline Management](#timeline-management)
6. [Documentation Requirements](#documentation-requirements)
7. [Regulatory Intelligence](#regulatory-intelligence)
8. [Communication Templates](#communication-templates)
9. [Quality Control Procedures](#quality-control-procedures)
10. [Related SOPs](#related-sops)
11. [References](#references)
12. [Appendices](#appendices)

## Purpose and Scope

### Purpose
[Describe the purpose of this Health Authority Communication Plan, including its role in establishing a framework for consistent, timely, and effective communications with regulatory authorities throughout the product lifecycle. Address the importance of strategic communications in building positive relationships with regulators and facilitating product development and approvals.]

### Scope
[Define the scope of the plan, including:
- Health authorities covered (FDA, EMA, PMDA, NMPA, Health Canada, etc.)
- Products/therapeutic areas included
- Phases of product lifecycle covered (development, registration, post-approval)
- Departments/functions involved
- Types of communications addressed]

### Regulatory Framework
[List relevant regulations and guidelines that govern communications with health authorities in applicable regions, such as:
- FDA guidance on meetings (PDUFA/GDUFA/BsUFA meeting guidances)
- EMA pre-submission meeting guidance
- ICH guidelines
- Regional requirements for communication during review
- Post-approval communication requirements]

## Communication Strategy

### Pre-Submission Communications

#### Strategic Planning
[Describe the approach for planning strategic interactions with health authorities before formal submissions, including:
- Timing considerations for initial engagement
- Alignment with product development milestones
- Value assessment of different meeting types
- Risk-based approach to communication planning]

#### Meeting Types
| Meeting Type | Purpose | Timing | Key Participants | Preparation Lead |
|-------------|---------|--------|------------------|------------------|
| Pre-IND/Scientific Advice | [Discuss development plans and gain feedback] | [Early development] | [List key roles] | [Role] |
| End-of-Phase 2 | [Align on Phase 3 design and registration strategy] | [After Phase 2 completion] | [List key roles] | [Role] |
| Pre-NDA/BLA/MAA | [Discuss content and format of planned submission] | [3-6 months before submission] | [List key roles] | [Role] |
| [Other meeting types] | [Purpose] | [Timing] | [List key roles] | [Role] |

#### Communication Objectives
[Outline objectives for pre-submission communications, such as:
- Gaining alignment on development strategy
- Clarifying regulatory expectations
- Obtaining preliminary feedback on critical issues
- Establishing relationships with reviewers
- Reducing risk of review issues]

### During Review Communications

#### Communication Planning
[Describe the approach for managing communications during the regulatory review period, including:
- Designating primary contact points
- Establishing internal coordination processes
- Preparing for different types of agency inquiries
- Tracking and triaging information requests]

#### Response Management Strategy
| Review Milestone | Expected Communications | Response Timeline | Internal Review Process | Escalation Pathway |
|------------------|-------------------------|------------------|------------------------|-------------------|
| Initial Filing/Validation | [Filing issues, validation questions] | [Timeline] | [Process] | [Escalation path] |
| Mid-cycle/Clock-stop | [Information requests, clarifications] | [Timeline] | [Process] | [Escalation path] |
| Late-cycle/Opinion | [Major objections, labeling discussions] | [Timeline] | [Process] | [Escalation path] |
| Advisory Committee | [Preparation, responses to questions] | [Timeline] | [Process] | [Escalation path] |
| [Other milestones] | [Expected communications] | [Timeline] | [Process] | [Escalation path] |

#### Risk Management
[Outline strategies for managing risks during the review period, including:
- Preparation for challenging questions
- Managing potentially negative feedback
- Addressing unexpected issues
- Handling disagreements with health authority positions]

### Post-Approval Communications

#### Ongoing Regulatory Obligations
[Describe the approach for managing required post-approval communications, including:
- Annual reports/PSURs/PBRERs
- Manufacturing changes
- Safety reporting
- Commitment fulfillment
- Label updates]

#### Proactive Communications
[Outline strategies for proactive communications with health authorities after approval, including:
- Regular status updates on post-approval commitments
- Scientific exchanges on emerging data
- Early notification of potential issues
- Relationship maintenance activities]

#### Communication Matrix
| Communication Type | Frequency | Responsible Person | Review Requirements | Submission Timeline |
|-------------------|-----------|-------------------|---------------------|---------------------|
| Annual Reports | [Annual] | [Role] | [Review process] | [Timeline] |
| PSURs/PBRERs | [Every 6 months/annually] | [Role] | [Review process] | [Timeline] |
| CMC Changes | [As needed] | [Role] | [Review process] | [Timeline] |
| Safety Reports | [15 days/7 days/periodic] | [Role] | [Review process] | [Timeline] |
| [Other types] | [Frequency] | [Role] | [Review process] | [Timeline] |

## Roles and Responsibilities

### Regulatory Affairs Team
| Role | Name | Responsibilities | Contact Information |
|------|------|-----------------|---------------------|
| Head of Regulatory Affairs | [Name] | [Strategic oversight, health authority relationships, escalation management] | [Phone/Email] |
| Regulatory Strategy Lead | [Name] | [Communication strategy development, meeting planning, key message development] | [Phone/Email] |
| Regulatory Operations | [Name] | [Submission management, correspondence tracking, document control] | [Phone/Email] |
| Regulatory CMC Lead | [Name] | [CMC communications, technical responses] | [Phone/Email] |
| Regulatory Clinical Lead | [Name] | [Clinical communications, efficacy/safety responses] | [Phone/Email] |
| [Additional roles] | [Name] | [Responsibilities] | [Phone/Email] |

### Subject Matter Experts
| Department | SME Name | Area of Expertise | Contact Information | Backup |
|------------|----------|-------------------|---------------------|--------|
| Clinical Development | [Name] | [Clinical trial design, clinical data] | [Phone/Email] | [Name] |
| Biostatistics | [Name] | [Statistical analysis, study design] | [Phone/Email] | [Name] |
| Nonclinical | [Name] | [Toxicology, pharmacology] | [Phone/Email] | [Name] |
| CMC/Manufacturing | [Name] | [Process, formulation, testing] | [Phone/Email] | [Name] |
| Quality | [Name] | [Quality systems, compliance] | [Phone/Email] | [Name] |
| Pharmacovigilance | [Name] | [Safety reporting, risk management] | [Phone/Email] | [Name] |
| [Additional departments] | [Name] | [Expertise] | [Phone/Email] | [Name] |

### Senior Management
| Role | Name | Communication Responsibilities | Approval Authority | Contact Information |
|------|------|----------------------------|-------------------|---------------------|
| Chief Medical Officer | [Name] | [Clinical strategy communications, benefit-risk discussions] | [Approval areas] | [Phone/Email] |
| Head of R&D | [Name] | [Overall development strategy] | [Approval areas] | [Phone/Email] |
| Quality Head | [Name] | [Quality/compliance communications] | [Approval areas] | [Phone/Email] |
| Chief Regulatory Officer | [Name] | [Overall regulatory strategy, critical health authority interactions] | [Approval areas] | [Phone/Email] |
| [Additional roles] | [Name] | [Responsibilities] | [Approval areas] | [Phone/Email] |

### RACI Matrix for Communications
[Provide a RACI (Responsible, Accountable, Consulted, Informed) matrix for different types of health authority communications]

| Communication Type | Regulatory Affairs | Clinical | CMC | Quality | Legal | Senior Management |
|-------------------|---------------------|---------|-----|---------|-------|-------------------|
| Meeting Requests | R/A | C | C | I | I | I |
| Briefing Packages | A | R (clinical) | R (CMC) | C | C | A |
| Information Responses | A | R (clinical) | R (CMC) | C | C | I |
| Safety Communications | C | C | I | C | C | A |
| Submission Strategies | R/A | C | C | C | C | A |
| Commitment Updates | A | R (clinical) | R (CMC) | C | I | I |

## Communication Procedures

### Written Communications

#### Correspondence Preparation Process
[Describe the process for preparing written communications to health authorities, including:
- Initiation and drafting responsibilities
- Internal review workflow
- Approval requirements based on communication type
- Quality control checks
- Submission procedures
- Record-keeping requirements]

#### Formatting Standards
[Outline the standards for written communications, including:
- Templates to be used
- Style and tone guidelines
- Data presentation formats
- Required elements (references, cross-references)
- Electronic submission requirements]

#### Timing Considerations
[Provide guidance on timing for different types of written communications, including:
- Statutory timelines for responses
- Internal timelines for preparation and review
- Considerations for complex or high-risk communications
- Managing urgent communications]

### Meetings and Teleconferences

#### Meeting Request Process
[Describe the process for requesting meetings with health authorities, including:
- Internal approval requirements
- Timing considerations
- Content requirements for meeting requests
- Follow-up procedures]

#### Meeting Preparation
| Timeline | Activity | Responsible Party | Deliverable |
|----------|----------|-------------------|-------------|
| 8-12 weeks before | Initiate meeting planning | [Role] | Meeting strategy document |
| 6-8 weeks before | Draft briefing package | [Role] | Draft briefing materials |
| 4-6 weeks before | Internal review of materials | [Role] | Reviewed materials |
| 3-4 weeks before | Finalize and submit materials | [Role] | Final briefing package |
| 2-3 weeks before | Prepare presentation slides | [Role] | Draft presentation |
| 1-2 weeks before | Conduct rehearsals | [Role] | Rehearsal feedback |
| 1 week before | Finalize logistics and presentation | [Role] | Final presentation |

#### Meeting Execution Guidelines
[Provide guidelines for effective health authority meetings, including:
- Roles and responsibilities during meetings
- Presentation best practices
- Question handling procedures
- Note-taking responsibilities
- Managing unexpected issues]

#### Post-Meeting Activities
[Describe post-meeting activities, including:
- Internal debriefing procedures
- Meeting minutes preparation
- Follow-up action identification
- Commitment tracking
- Learnings documentation]

### Responses to Authority Queries

#### Query Management Process
[Describe the process for managing and responding to health authority queries, including:
- Receipt and logging procedures
- Triage and prioritization
- Assignment to responders
- Coordination of complex responses
- Review and approval workflow
- Submission procedures]

#### Response Timelines
| Query Type | Authority | Standard Timeline | Expedited Timeline | Internal Deadline |
|------------|-----------|-------------------|---------------------|------------------|
| Information Request | FDA | 30 days | 5-10 days | 5 days before due |
| 74-Day Letter | FDA | 74 days | N/A | 10 days before due |
| List of Questions | EMA | 3 months | N/A | 2 weeks before due |
| Clock Stop | EMA | Varies | N/A | 2 weeks before due |
| [Other query types] | [Authority] | [Timeline] | [Timeline] | [Internal deadline] |

#### Response Quality Standards
[Outline quality standards for responses, including:
- Completeness requirements
- Clarity expectations
- Data presentation standards
- Cross-referencing guidance
- Consistency checks]

## Timeline Management

### Submission Planning

#### Submission Calendar
[Describe the approach for maintaining a submission calendar, including:
- Planning horizon (1-5 years)
- Update frequency
- Coordination with development timelines
- Resource planning considerations
- Regional submission sequencing]

#### Critical Path Management
[Outline the approach for managing the critical path to submissions, including:
- Key milestone identification
- Dependency mapping
- Timeline risk assessment
- Contingency planning
- Progress tracking methods]

#### Planning Tools
[Describe the tools used for submission planning, such as:
- Project management software
- Gantt charts
- Tracking dashboards
- Resource allocation tools
- Calendar integration]

### Review Cycles

#### Review Clock Management
[Describe the approach for tracking and managing review clocks, including:
- Clock start definitions by authority
- Stop clock provisions
- Extension scenarios
- Milestone tracking
- Notification procedures for timeline changes]

#### Review Milestone Planning
| Review Phase | Expected Timeline | Key Milestones | Preparation Activities | Responsible Party |
|--------------|-------------------|----------------|------------------------|-------------------|
| Initial Review | [Timeline] | [Milestones] | [Activities] | [Role] |
| Mid-cycle | [Timeline] | [Milestones] | [Activities] | [Role] |
| Late-cycle | [Timeline] | [Milestones] | [Activities] | [Role] |
| Advisory Committee | [Timeline] | [Milestones] | [Activities] | [Role] |
| Action Date | [Timeline] | [Milestones] | [Activities] | [Role] |
| [Other phases] | [Timeline] | [Milestones] | [Activities] | [Role] |

#### Multi-region Coordination
[Outline the approach for coordinating review activities across multiple regions, including:
- Alignment of responses when possible
- Managing regional differences
- Resource allocation across parallel reviews
- Leveraging learnings across regions]

### Response Deadlines

#### Deadline Tracking System
[Describe the system for tracking response deadlines, including:
- Centralized tracking database/tool
- Responsibility for updates
- Alert/notification system
- Escalation procedures for at-risk deadlines]

#### Internal Timeline Management
[Outline the approach for managing internal timelines to meet health authority deadlines, including:
- Standard lead times for different response types
- Resource allocation guidelines
- Review cycle timing
- Quality control timing
- Submission preparation timing]

#### Extension Requests
[Provide guidance on requesting extensions to response deadlines, including:
- Criteria for considering extensions
- Internal approval requirements
- Preparation of extension requests
- Alternative approaches when extensions cannot be granted]

## Documentation Requirements

### Communication Records

#### Record Types
[List the types of communications that must be documented, such as:
- Formal written correspondence
- Email communications
- Telephone conversations
- Face-to-face meetings
- Video/teleconferences
- Scientific advice
- Informal discussions]

#### Documentation Standards
[Outline standards for documenting communications, including:
- Required content
- Format requirements
- Supporting documentation
- Review and approval requirements
- Storage location and duration]

#### Archiving Requirements
[Describe requirements for archiving communication records, including:
- Retention periods
- Storage systems
- Access controls
- Retrieval procedures
- Backup provisions]

### Meeting Minutes

#### Content Requirements
[Outline the required content for meeting minutes, including:
- Meeting details (date, time, participants)
- Agenda items
- Key discussion points
- Health authority feedback
- Agreements reached
- Action items
- Commitments made
- Next steps]

#### Preparation Process
[Describe the process for preparing meeting minutes, including:
- Responsibility for drafting
- Timing requirements
- Review workflow
- Approval requirements
- Distribution procedures
- Filing requirements]

#### Minutes Template
[Provide a template or reference to a template for meeting minutes to ensure consistency]

### Correspondence Tracking

#### Tracking System
[Describe the system used to track health authority correspondence, including:
- Database/tool used
- Information captured
- Responsibility for entries
- Search capabilities
- Reporting functions]

#### Tracking Metrics
[List metrics tracked for health authority communications, such as:
- Volume by communication type
- Response times
- Quality metrics (e.g., rejection rates)
- Query patterns
- Resolution times
- Commitment fulfillment]

#### Reporting Requirements
[Outline reporting requirements for health authority communications, including:
- Report types
- Frequency
- Distribution
- Review process
- Action planning based on metrics]

## Regulatory Intelligence

### Authority Updates

#### Intelligence Sources
[List sources of regulatory intelligence to be monitored, such as:
- Authority websites
- Regulatory newsletters
- Industry associations
- Conferences
- Webinars
- Consultant updates
- Peer networks]

#### Monitoring Process
[Describe the process for monitoring health authority updates, including:
- Responsibility for monitoring
- Frequency of monitoring
- Documentation of findings
- Initial assessment of relevance
- Distribution of information]

#### Priority Classification
[Outline the system for classifying the priority of regulatory updates, including:
- Criteria for high, medium, and low priority
- Impact assessment guidelines
- Urgency determination
- Action requirements by priority level]

### Guidance Monitoring

#### Guidance Tracking
[Describe the system for tracking new and revised guidance documents, including:
- Database/tool used
- Information captured
- Update frequency
- Responsibility for maintenance
- Alert/notification system]

#### Draft Guidance Engagement
[Outline the approach for engaging with draft guidance documents, including:
- Review process
- Comment preparation
- Approval requirements for comments
- Submission procedures
- Tracking of final guidance publication]

#### Guidance Implementation
[Describe the process for implementing new guidance requirements, including:
- Gap assessment methodology
- Implementation planning
- Resource allocation
- Timeline development
- Progress tracking]

### Impact Assessment

#### Assessment Methodology
[Outline the methodology for assessing the impact of regulatory changes, including:
- Initial screening criteria
- Detailed assessment approach
- Cross-functional input
- Risk evaluation
- Documentation requirements]

#### Impact Categories
[List categories of potential impact to be assessed, such as:
- Product development strategy
- Clinical trial designs
- Manufacturing processes
- Analytical methods
- Submission content
- Labeling requirements
- Post-approval obligations]

#### Action Planning
[Describe the process for developing action plans based on impact assessments, including:
- Responsibility for plan development
- Required elements
- Review and approval
- Implementation oversight
- Effectiveness evaluation]

## Communication Templates

### Meeting Request Templates

#### FDA Meeting Requests
[Provide templates or guidance for different FDA meeting types, such as:
- Type A, B, B(EOP), C meetings
- Pre-IND meetings
- End-of-Phase 2 meetings
- Pre-NDA/BLA meetings
- Required content for each meeting type]

#### EMA Meeting Requests
[Provide templates or guidance for different EMA meeting types, such as:
- Scientific advice
- Pre-submission meetings
- Rapporteur meetings
- Required content for each meeting type]

#### Other Health Authority Meeting Requests
[Provide templates or guidance for meeting requests with other health authorities, such as:
- PMDA consultation meetings
- Health Canada pre-submission meetings
- NMPA communications
- Required content for each meeting type]

### Briefing Documents

#### Briefing Document Structure
[Outline the standard structure for briefing documents, including:
- Executive summary
- Background
- Purpose of the meeting
- Meeting objectives
- Questions for discussion
- Data presentation
- References]

#### Content Guidelines
[Provide guidelines for briefing document content, including:
- Level of detail appropriate for different meeting types
- Data presentation standards
- Referencing requirements
- Appendix usage
- Formatting requirements]

#### Quality Standards
[Outline quality standards for briefing documents, including:
- Scientific rigor
- Data integrity
- Logical flow
- Clarity of questions
- Supporting evidence
- Consistent terminology]

### Response Letters

#### Standard Response Format
[Provide the standard format for response letters, including:
- Header information
- Reference to original query
- Introduction
- Response structure
- Supporting data presentation
- Conclusion
- References]

#### Response Strategies
[Provide guidance on response strategies for different query types, such as:
- Clarification requests
- Data requests
- Methodology questions
- Safety concerns
- Efficacy questions
- CMC issues]

#### Language Guidelines
[Outline guidelines for language and tone in responses, including:
- Professional tone
- Clarity requirements
- Technical language considerations
- Conciseness
- Avoiding ambiguity
- Addressing all aspects of the query]

## Quality Control Procedures

### Review Process

#### Review Levels
[Describe the different levels of review required for health authority communications, such as:
- Technical accuracy review
- Scientific review
- Regulatory strategy review
- Legal/compliance review
- Senior management review]

#### Review Workflow
[Outline the standard workflow for reviewing communications, including:
- Sequential vs. parallel review steps
- Typical timeframes for different review steps
- Handling of reviewer comments
- Conflict resolution procedures
- Final approval requirements]

#### Review Tools
[Describe tools used to facilitate the review process, such as:
- Document management systems
- Comment tracking tools
- Version control systems
- Electronic review/approval systems
- Collaborative editing platforms]

### Approval Chain

#### Approval Requirements Matrix
[Provide a matrix showing approval requirements for different communication types]

| Communication Type | Subject Expert | Regulatory Lead | Quality | Legal | Senior Management |
|-------------------|----------------|-----------------|---------|-------|-------------------|
| Meeting Requests | ✓ | ✓ | | | |
| Briefing Documents | ✓ | ✓ | ✓ | ✓ | ✓ |
| Response to Minor Queries | ✓ | ✓ | | | |
| Response to Major Queries | ✓ | ✓ | ✓ | ✓ | ✓ |
| Commitment Updates | ✓ | ✓ | ✓ | | |
| [Other types] | [Requirements] | [Requirements] | [Requirements] | [Requirements] | [Requirements] |

#### Delegation of Authority
[Outline the policy for delegation of approval authority, including:
- Circumstances allowing delegation
- Documentation requirements
- Limitations on delegation
- Training requirements for delegates
- Verification procedures]

#### Emergency Approval Process
[Describe the expedited approval process for urgent communications, including:
- Criteria for invoking emergency process
- Streamlined workflow
- Minimum approvals required
- Documentation requirements
- Post-submission review]

### Version Control

#### Versioning System
[Describe the versioning system for health authority communications, including:
- Version numbering convention
- Draft vs. final designation
- Revision identification
- Approval status indicators
- Distribution indicators]

#### Change Management
[Outline procedures for managing changes to communications, including:
- Change request process
- Impact assessment
- Re-review requirements
- Version update procedures
- Change documentation]

#### Final Document Control
[Describe controls for final documents, including:
- Finalization procedures
- Electronic signature requirements
- Copy control
- Protected file formats
- Storage requirements
- Retrieval procedures]

## Related SOPs

### Document Control and Records Management SOP
- **SOP Number:** QMS-DC-001
- **Purpose:** Establishes standards for document control and records management across regulatory communications
- **Key Interfaces:**
  - Defines versioning and document control requirements for all health authority communications
  - Establishes retention periods for different types of regulatory records
  - Outlines archival and retrieval procedures for communication records

### Regulatory Submissions Management SOP
- **SOP Number:** REG-SUB-001
- **Purpose:** Governs the preparation, review, and submission of regulatory documents
- **Key Interfaces:**
  - Details submission preparation workflows
  - Establishes quality control procedures for submissions
  - Defines roles and responsibilities in the submission process

### Health Authority Meeting Management SOP
- **SOP Number:** REG-MTG-001
- **Purpose:** Provides procedures for planning, conducting, and following up on health authority meetings
- **Key Interfaces:**
  - Outlines meeting request procedures
  - Details briefing document preparation requirements
  - Establishes meeting documentation standards

### Regulatory Intelligence Management SOP
- **SOP Number:** REG-INT-001
- **Purpose:** Establishes processes for gathering, analyzing, and disseminating regulatory intelligence
- **Key Interfaces:**
  - Defines monitoring procedures for regulatory updates
  - Outlines impact assessment methodology
  - Details communication procedures for regulatory changes

### Regulatory Communications Review and Approval SOP
- **SOP Number:** REG-COM-001
- **Purpose:** Defines review and approval requirements for health authority communications
- **Key Interfaces:**
  - Establishes review workflows and timelines
  - Details approval requirements by communication type
  - Outlines documentation requirements for reviews

### Query Management SOP
- **SOP Number:** REG-QRY-001
- **Purpose:** Governs the receipt, tracking, and response to health authority queries
- **Key Interfaces:**
  - Defines query triage and prioritization procedures
  - Establishes response preparation workflows
  - Details quality control requirements for responses

### Commitment Tracking and Management SOP
- **SOP Number:** REG-CMT-001
- **Purpose:** Establishes procedures for tracking and fulfilling regulatory commitments
- **Key Interfaces:**
  - Outlines commitment identification and documentation
  - Defines tracking and monitoring procedures
  - Details commitment fulfillment requirements

### Regulatory Archive Management SOP
- **SOP Number:** REG-ARC-001
- **Purpose:** Governs the archival and maintenance of regulatory communications
- **Key Interfaces:**
  - Establishes archival procedures and standards
  - Defines access control requirements
  - Details retrieval procedures for archived communications

## References

1. FDA Guidance for Industry: Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
2. FDA Guidance for Industry: Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products
3. EMA Pre-authorization Guidance
4. EMA Guideline on Procedures for Scientific Advice
5. ICH E6(R3): Good Clinical Practice
6. ICH M4: Common Technical Document
7. [Regional health authority communication guidances]
8. [Company SOPs as referenced in Related SOPs section]

## Appendices

### Appendix A: Meeting Request Templates
[Provide templates for different types of meeting requests with various health authorities]

### Appendix B: Response Letter Templates
[Provide templates for different types of response letters]

### Appendix C: Communication Tracking Log
[Provide a template for tracking health authority communications]

| Date | Communication Type | Health Authority | Product | Topic | Responsible Person | Due Date | Status | Follow-up Actions |
|------|-------------------|------------------|---------|-------|-------------------|----------|--------|-------------------|
| | | | | | | | | |

### Appendix D: Health Authority Contact Directory
[Provide a directory of key health authority contacts]

| Health Authority | Division/Department | Contact Name | Position | Email | Phone | Address |
|-----------------|---------------------|--------------|----------|-------|-------|---------|
| | | | | | | |

### Appendix E: Regulatory Meeting Checklist
[Provide a checklist for preparing for regulatory meetings]

**Pre-Meeting Preparation:**
- [ ] Meeting request prepared and approved
- [ ] Meeting objectives defined
- [ ] Briefing book prepared and approved
- [ ] Presentation slides prepared and approved
- [ ] Presenters identified and prepared
- [ ] Q&A document prepared
- [ ] Pre-meeting rehearsal conducted
- [ ] Logistics confirmed

**Meeting Materials:**
- [ ] Agenda
- [ ] Presentation copies
- [ ] Supporting data
- [ ] Product samples (if applicable)
- [ ] Business cards
- [ ] Note-taking materials
- [ ] Contact information

**Post-Meeting Activities:**
- [ ] Internal debrief conducted
- [ ] Meeting minutes prepared
- [ ] Action items identified and assigned
- [ ] Commitments documented
- [ ] Follow-up communications prepared
- [ ] Documentation filed

### Appendix F: Query Response Checklist
[Provide a checklist for preparing responses to health authority queries]

- [ ] Query understood and clarified if needed
- [ ] Response strategy developed
- [ ] Supporting data identified and collected
- [ ] Response drafted
- [ ] Quality control checks completed
- [ ] All required reviews completed
- [ ] Final approval obtained
- [ ] Response submitted
- [ ] Submission confirmation received
- [ ] Response archived

---

*Note: This template should be customized based on the specific types of products, applicable regulatory frameworks, and organizational structure. Regular updates should be performed to incorporate lessons learned from health authority interactions and changes in regulatory expectations.*